HomeComparePLHHX vs JNJ

PLHHX vs JNJ: Dividend Comparison 2026

PLHHX yields 3.95% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLHHX wins by $5.8K in total portfolio value
10 years
PLHHX
PLHHX
● Live price
3.95%
Share price
$17.53
Annual div
$0.69
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.9K
Annual income
$508.73
Full PLHHX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — PLHHX vs JNJ

📍 PLHHX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPLHHXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PLHHX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PLHHX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PLHHX
Annual income on $10K today (after 15% tax)
$335.59/yr
After 10yr DRIP, annual income (after tax)
$432.42/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $271.19/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PLHHX + JNJ for your $10,000?

PLHHX: 50%JNJ: 50%
100% JNJ50/50100% PLHHX
Portfolio after 10yr
$22.9K
Annual income
$668.25/yr
Blended yield
2.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PLHHX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PLHHX buys
0
JNJ buys
0
No recent congressional trades found for PLHHX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPLHHXJNJ
Forward yield3.95%3.36%
Annual dividend / share$0.69$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$25.9K$20.0K
Annual income after 10y$508.73$827.78
Total dividends collected$4.5K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PLHHX vs JNJ ($10,000, DRIP)

YearPLHHX PortfolioPLHHX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,095$394.81$10,676$355.77+$419.00PLHHX
2$12,281$409.38$11,407$389.39+$874.00PLHHX
3$13,564$423.49$12,198$426.53+$1.4KPLHHX
4$14,951$437.14$13,056$467.62+$1.9KPLHHX
5$16,447$450.31$13,987$513.12+$2.5KPLHHX
6$18,062$462.98$14,998$563.56+$3.1KPLHHX
7$19,801$475.16$16,098$619.52+$3.7KPLHHX
8$21,674$486.85$17,295$681.69+$4.4KPLHHX
9$23,689$498.03$18,599$750.82+$5.1KPLHHX
10$25,856$508.73$20,022$827.78+$5.8KPLHHX

PLHHX vs JNJ: Complete Analysis 2026

PLHHXStock

The fund operates as a "target date fund" that invests according to an asset allocation strategy designed for investors having a retirement investment goal close to the year in 2065. It is a fund of funds that invests in underlying funds of Principal Funds, Inc. ("PFI"), with a majority of the fund's assets invested in index funds. Its underlying funds consist of domestic and foreign equity funds, fixed-income funds, real asset funds, and other funds that aim to offer diversification beyond traditional equity and fixed-income securities.

Full PLHHX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this PLHHX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PLHHX vs SCHDPLHHX vs JEPIPLHHX vs OPLHHX vs KOPLHHX vs MAINPLHHX vs ABBVPLHHX vs MRKPLHHX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.